Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CUV1647 (Afamelanotide) Implant for Solar Urticaria
NCT00859534Phase 2Completed
- Sponsor
- Clinuvel Pharmaceuticals
- Start
- Dec 2008
- Primary completion
- Jun 2009
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Afamelanotide in solar urticaria (SU), sponsored by Clinuvel Pharmaceuticals. Started Dec 2008; status: completed.
02
Drugs
Afamelanotide
03
Conditions
solar urticaria (SU)
Beyond the preview
Go deeper on NCT00859534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00859534.